Riskpilot← Back to searchSign inGet full accessApotek A AB
ABActiveOrg 5592168735Sibeliusgången 24 ERetail sale of pharmaceutical products · NACE 4773Est. 20191 employees
Revenue 2025
SEK 9,1M
+19% vs 2024
EBITDA margin
5.6%
+1113% vs 2024
Equity ratio
24.4%
Financial strength
Net profit 2025
SEK 477K
+865% vs 2024
| Revenue | SEK 9,1M | +19% |
| EBITDA | SEK 511K | +1113% |
| Net profit | SEK 477K | +865% |
| Total assets | SEK 2,2M | +11% |
| Equity | SEK 529K | +919% |
| Employees | 1 | — |
Legal name
Apotek A AB
Org number
5592168735
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2 september 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
-Bedriva apoteksverksamhet med receptbelagda & receptfria mediciner, samt hälsokostförsäljning. -Förnyelse av recept via läkare per telefon och elektroniska recept. -Skall utföra enkla provtagningar & öronhåltagning.
Address
Sibeliusgången 24 E
Email
karezo@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 485 | 5 214 | 5 659 | 7 673 | 9 107 |
| Staff expenses | — | −681 | −31 | −4 | −92 |
| EBITDA | −516 | −401 | −58 | 42 | 511 |
| Depreciation & amort. | −91 | −91 | −91 | −91 | −29 |
| EBIT | −607 | −492 | −149 | −49 | 482 |
| Net financials | −1 | 0 | 0 | −13 | −5 |
| Profit before tax | −609 | −492 | −149 | −62 | 477 |
| Tax | −0 | — | — | — | — |
| Net profit | −609 | −492 | −149 | −62 | 477 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 089 | 1 784 | 1 802 | 1 952 | 2 165 |
| Equity | 52 | 50 | 51 | 52 | 529 |
| Long-term debt | 1 421 | 1 083 | 696 | 794 | 410 |
| Short-term debt | 616 | 651 | 1 054 | 1 107 | 1 225 |
| Total debt | 2 037 | 1 734 | 1 751 | 1 901 | 1 636 |
EBITDA margin
5.6%
This company
15.8%
Market median
-65% vs market
20212025
Equity ratio
24.4%
This company
38.2%
Market median
-36% vs market
20212025
Return on equity
90.2%
This company
18.4%
Market median
+390% vs market
20212025
Net profit margin
5.2%
This company
8.1%
Market median
-36% vs market
20212025
Asset turnover
4.21×
This company
1.12×
Market median
+276% vs market
20212025
Debt / equity
3.09×
This company
0.62×
Market median
-398% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apotek A AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karezo Kamalla | Chief Executive Officer | 0 companies |
| Cloude Suliman | Deputy Board Member | 0 companies |